STAAR Surgical Company

STAA · NASDAQ
Analyze with AI
11/5/2025
9/26/2025
6/27/2025
3/28/2025
Operating Activities
Net Income$8,884-$16,812-$54,211
Dep. & Amort.$2,000$1,975$2,337
Deferred Tax$9,906-$9,595-$1,029
Stock-Based Comp.$8,158$7,802$6,015
Change in WC-$30,787-$15,867$29,403
Other Non-Cash$4,506$5,248$11,751
Operating Cash Flow$2,667-$27,249-$5,734
Investing Activities
PP&E Inv.-$883-$1,792-$1,468
Net Acquisitions$0$0$0
Inv. Purchases-$11,773$0-$14,691
Inv. Sales/Matur.$17,939$26,912$51,510
Other Inv. Act.$0$0$0
Investing Cash Flow$5,283$25,120$35,351
Financing Activities
Debt Repay.$0$0-$42
Stock Issued$1$12$0
Stock Repurch.-$1,982-$4,479-$1,283
Dividends Paid$0$0$0
Other Fin. Act.$2,964-$73$377
Financing Cash Flow$983-$4,540-$948
Forex Effect$91$686$286
Net Chg. in Cash$9,024-$5,983$28,955
Supplemental Information
Beg. Cash$167,131$173,114$144,159
End Cash$176,155$167,131$173,114
Free Cash Flow$1,784-$29,041-$7,202
STAAR Surgical Company (STAA) Financial Statements & Key Stats | AlphaPilot